Surgery for left-sided pancreatic cancer

Area of Science:

• Gastroenterology
• Surgical Oncology
• Oncology

Background:

• Exocrine pancreatic cancer of the body or tail poses significant treatment challenges.
• Surgical intervention strategies range from resection to palliative procedures.

Purpose of the Study:

• To analyze the outcomes of different surgical approaches for exocrine pancreatic cancer.
• To identify patient subgroups who benefit most from curative resection versus palliative surgery.

Main Methods:

• Retrospective analysis of 590 patients with exocrine pancreatic cancer (body/tail) undergoing surgery between 1982-1988.
• Comparison of outcomes (mortality, morbidity, survival) across three groups: pancreatic resection (128), palliative bypass (164), and exploratory laparotomy/splanchnicectomy (293).

Main Results:

• Pancreatic resection showed a significantly lower mortality rate (9%) compared to palliative bypass (19%).
• High mortality (>40%) observed in both groups for patients over 70 with organ failure.
• Patients with metastases had a median survival of 3.4 months irrespective of treatment.
• Only patients with small tumors (<4cm), no lymph node involvement, and no metastases significantly benefited from resection (1- and 3-year survival 38% and 12%).

Conclusions:

• Curative pancreatic resection should be reserved for a small subset of patients (<10%) with localized tumors confined to the pancreas.
• For most patients, pancreatic resection serves as a palliative procedure without significant survival improvement.
• Palliative surgery should be limited to candidates for digestive bypass, with non-surgical palliation for others.